Scarica l'app Stockscreener
520.57
1.16%
-6.09
Dopo l'orario di chiusura:
520.63
0.06
+0.01%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IDXX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$526.66
Aprire:
$517
Volume 24 ore:
471.57K
Relative Volume:
0.72
Capitalizzazione di mercato:
$41.87B
Reddito:
$3.93B
Utile/perdita netta:
$894.97M
Rapporto P/E:
48.11
EPS:
10.82
Flusso di cassa netto:
$837.70M
1 W Prestazione:
-3.71%
1M Prestazione:
-1.55%
6M Prestazione:
+21.45%
1 anno Prestazione:
+4.21%
Intervallo 1D:
$506.91
$521.27
Intervallo di 1 settimana:
$506.91
$548.53
Portata 52W:
$356.14
$549.52
Idexx Laboratories Inc Stock (IDXX) Company Profile
Nome
Idexx Laboratories Inc
Settore
Industria
Telefono
(207) 556-0300
Indirizzo
ONE IDEXX DRIVE, WESTBROOK, ME
Confronta IDXX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
520.57 | 43.48B | 3.93B | 894.97M | 837.70M | 10.82 |
|
TMO
Thermo Fisher Scientific Inc
|
416.31 | 158.50B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
193.30 | 143.82B | 23.82B | 3.77B | 4.90B | 5.15 |
|
A
Agilent Technologies Inc
|
113.43 | 34.46B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
158.64 | 28.03B | 15.50B | 1.33B | 2.16B | 7.34 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-01 | Iniziato | Jefferies | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Outperform |
| 2024-07-25 | Iniziato | BTIG Research | Buy |
| 2024-01-30 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-12-04 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Downgrade | Stifel | Buy → Hold |
| 2022-07-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-07-12 | Iniziato | Piper Sandler | Overweight |
| 2022-05-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-02-08 | Iniziato | Atlantic Equities | Overweight |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-12 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-02-17 | Iniziato | Barclays | Overweight |
| 2019-09-09 | Iniziato | Goldman | Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Buy |
| 2018-11-02 | Reiterato | BofA/Merrill | Buy |
| 2018-05-07 | Reiterato | Stifel | Buy |
| 2018-01-16 | Iniziato | Piper Jaffray | Overweight |
| 2017-08-23 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Aggiornamento | CL King | Neutral → Buy |
| 2017-02-03 | Downgrade | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Ripresa | BofA/Merrill | Neutral |
| 2016-08-16 | Reiterato | Stifel | Buy |
| 2016-08-03 | Aggiornamento | Northcoast | Sell → Neutral |
| 2016-07-20 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-19 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-01 | Iniziato | CL King | Neutral |
| 2016-03-21 | Reiterato | Stifel | Buy |
| 2016-02-04 | Iniziato | Credit Suisse | Outperform |
| 2015-10-29 | Reiterato | Stifel | Buy |
| 2015-08-28 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Reiterato | Stifel | Buy |
| 2015-07-23 | Reiterato | Canaccord Genuity | Buy |
Mostra tutto
Idexx Laboratories Inc Borsa (IDXX) Ultime notizie
Here's What to Expect From IDEXX Laboratories' Next Earnings Report - Yahoo Finance
Here's What To Expect From IDEXX Laboratories' Next Earnings Report - Barchart.com
IDEXX Laboratories (IDXX) Announces Election of New Independent Director - GuruFocus
IDEXX Laboratories Appoints Joseph L. (Jay) Hooley To Board - citybiz
IDEXX Laboratories Expands Board with New Director - TipRanks
IDEXX Laboratories Elects Joseph L. (Jay) Hooley to Board of Directors - AInvest
What Does IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Indicate? - Yahoo Finance
Here's How Much You'd Have If You Invested $1000 in Idexx Laboratories a Decade Ago - Yahoo Finance
IDEXX Laboratories Insiders Sell US$2.4m Of Stock, Possibly Signalling Caution - simplywall.st
Stifel Nicolaus Issues Positive Forecast for IDEXX Laboratories (NASDAQ:IDXX) Stock Price - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Coverage Initiated by Analysts at Jefferies Financial Group - MarketBeat
Idexx Laboratories stock hits 52-week high at $546.61 By Investing.com - Investing.com South Africa
Idexx Laboratories stock hits 52-week high at $546.61 - Investing.com
IDEXX Laboratories (IDXX) Price Target Raised by Stifel | IDXX Stock News - GuruFocus
(PDF) Performance comparison of SNAP® 4Dx® plus and AccuPlex®4 for the detection of antibodies to Borrelia burgdorferi and Anaplasma phagocytophilum - researchgate.net
Stifel Adjusts Price Target on IDEXX Laboratories to $540 From $510, Maintains Hold Rating - MarketScreener
Investing in IDEXX Laboratories (NASDAQ:IDXX) Five Years Ago Would Have Delivered You a 58% Gain - 富途牛牛
IDEXX Laboratories, Inc.(NasdaqGS: IDXX) dropped from Russell 1000 Dynamic Index - MarketScreener
(PDF) Validation of immune complex dissociation methods for use with heartworm antigen tests - researchgate.net
What Makes IDEXX Laboratories (IDXX) a Good Investment? - Insider Monkey
IDEXX Laboratories to Release 2025 Second Quarter Financial Results | IDXX Stock News - GuruFocus
Idexx Laboratories stock hits 52-week high at $530.74 By Investing.com - Investing.com UK
IDEXX Laboratories (IDXX) Price Target Hiked to $580 at Leerink Partners - Insider Monkey
12 Best Healthcare Stocks to Buy Now - Insider Monkey
IDEXX Laboratories Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga
IDEXX Laboratories (IDXX) Sees Price Target Raised by Leerink Pa - GuruFocus
Three Lawmakers Bought This Biotech Stock Before Supporting A Bill That Could Boost Its Value: It's Now Up 44% - Benzinga
Is IDEXX Laboratories Stock Outperforming The Dow? - Barchart.com
Is IDEXX Laboratories Stock Outperforming the Dow? - The Globe and Mail
Leerink Partners Adjusts IDEXX Laboratories Price Target to $580 From $515 - MarketScreener
Kalkine : IDEXX Laboratories Performance Within S&P 500 Index Framework - Kalkine Media
IDEXX Labs $IDXX Sees Surge in Political Buys: 3 Politicians on Agriculture Committees Invest – Crypto Market Eyes Regulatory Impact - Blockchain News
IDEXX Catalyst Cortisol Rapid Canine Dx - Precedence Research
Amazon Delivery Robots Could Haunt Your Front Porch - Yahoo! Autos
Jim Cramer on IDEXX Laboratories, Inc. (IDXX): “I Just Can’t Get My Arms Around It” - MSN
Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders - StreetInsider
IDEXX Laboratories (IDXX) Stock Analysis: A Look at Its Robust 59.33% ROE Amidst Market Challenges - DirectorsTalk Interviews
Jim Cramer’s Thoughts on These 10 Stocks - Insider Monkey
IDEXX Laboratories (NASDAQ:IDXX) Stock Rating Lowered by Wall Street Zen - Defense World
Companion Animal Diagnostics Market Is Booming WorldwideIDEXX Laboratories, Heska Corporation - openPR.com
Transcript : IDEXX Laboratories, Inc. Presents at Stifel Jaws & Paws Conference 2025, May-28-2025 10 - marketscreener.com
IDEXX Laboratories To Present At Stifel Jaws & Paws Conference; Webcast At 10:55 AM ET - Nasdaq
IDEXX Laboratories Stock: Analyst Estimates & Ratings - MSN
IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - simplywall.st
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
IDEXX Lab jumps after Q1 beat and guidance raise - MSN
$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today - Benzinga
IDEXX Laboratories (NASDAQ:IDXX) Given New $510.00 Price Target at Stifel Nicolaus - Defense World
IDEXX Laboratories (IDXX) Target Price Raised by Stifel to $510 | IDXX Stock News - GuruFocus
If You Invested $1000 in Idexx Laboratories a Decade Ago, This is How Much It'd Be Worth Now - Yahoo Finance
Idexx Laboratories (IDXX) Price Target Increased by Stifel Analy - GuruFocus
Idexx Laboratories Inc Azioni (IDXX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.43%
0.97%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):